Mkts

Exagen Inc.

NASDAQ: XGN
$7.27-0.21 (-2.81%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
7.177.46
52-week range
2.5912.23
Today
Open7.43
Previous close7.27
Volume—
Valuation
Market cap177.06M
P/E ratio—
EPS (TTM)-0.81
Income & risk
Dividend / yield—
Beta2.29
Avg volume324.5K
Discussion

XGN News

Stories mentioning XGN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue17,30616,63117,24417,20215,49813,65512,50715,064
Cost of Goods Sold7,1017,4257,1696,8076,3755,1785,5266,008
Gross Profit10,2059,20610,07510,3959,1238,4776,9819,056
Operating Expenses
Research & Development1,5531,7571,7301,4831,2841,6561,4811,179
Sales General & Admin12,06612,42411,44511,54211,20410,20410,16310,464
Total Operating Expenses
Operating Income (Loss)(3,414)(4,975)(3,100)(2,630)(3,365)(3,383)(4,663)(2,587)
Interest Income43.003.0085.00158.00197.00197.00181.00
Interest Expense
Other Expense(132.00)158.00
Pretax Income
Tax Provision36.0013.001.0037.000.000.000.00
Net Income (Loss)(3,967)(4,673)(7,087)(4,439)(3,752)(3,761)(5,028)(2,966)
Earnings Per Share (Basic)(0.17)(0.22)(0.31)(0.21)(0.20)(0.21)(0.28)(0.16)
Earnings Per Share (Diluted)(0.17)(0.22)(0.31)(0.21)(0.20)(0.21)(0.28)(0.16)
Weighted Average Shares Outstanding (Basic)23,85521,55822,94021,08618,55718,20318,25518,178
Weighted Average Shares Outstanding (Diluted)23,85521,55822,94021,08618,55718,20318,25518,178

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About XGN

Exagen Inc. (NASDAQ: XGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol XGN. It last traded at $7.27 (Oct 23, 2026, 4:00 PM ET), down 2.8% on the day. That gives Exagen a market capitalisation of $177.1M.

Over the past 52 weeks XGN has traded between $2.59 and $12.23.

Revenue for the quarter ended Mar 31, 2026 was $17.3M; a net loss of $4.0M. Revenue was up 11.7% from $15.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$17.3M-$4.0M-22.9%
Dec 31, 2025$16.6M-$4.7M-28.1%
Sep 30, 2025$17.2M-$7.1M-41.1%
Jun 30, 2025$17.2M-$4.4M-25.8%

From Exagen’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…